These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2202885

  • 1. Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy.
    Krentz AJ, Coles NH, Williams AC, Nattrass M.
    Metabolism; 1990 Sep; 39(9):938-42. PubMed ID: 2202885
    [Abstract] [Full Text] [Related]

  • 2. Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy.
    Krentz AJ, Williams AC, Nattrass M.
    Metabolism; 1991 Aug; 40(8):866-72. PubMed ID: 1861635
    [Abstract] [Full Text] [Related]

  • 3. Impaired glucose tolerance is characterized by multiple abnormalities in the regulation of intermediary metabolism.
    Krentz AJ, Singh BM, Nattrass M.
    Diabet Med; 1991 Nov; 8(9):848-54. PubMed ID: 1837511
    [Abstract] [Full Text] [Related]

  • 4. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA, Singh BM, Nattrass M.
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [Abstract] [Full Text] [Related]

  • 5. Metabolic abnormalities in obese patients with impaired glucose tolerance.
    Robertson DA, Singh BM, Baddeley RM, Nattrass M.
    Diabet Med; 1990 Jan; 7(1):45-9. PubMed ID: 2137062
    [Abstract] [Full Text] [Related]

  • 6. Abnormal regulation of carbohydrate metabolism in motor neurone disease.
    Krentz AJ, Williams AC, Nattrass M.
    Diabetes Res; 1991 Feb; 16(2):93-9. PubMed ID: 1817811
    [Abstract] [Full Text] [Related]

  • 7. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
    Krentz AJ, Singh BM, Hale PJ, Robertson DA, Nattrass M.
    Diabetes Res; 1992 Feb; 20(3):51-60. PubMed ID: 1345002
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Abnormal regulation of venous alanine after glucose ingestion in myotonic dystrophy.
    Moxley RT, Kingston W, Griggs RC.
    Clin Sci (Lond); 1985 Feb; 68(2):151-7. PubMed ID: 3881207
    [Abstract] [Full Text] [Related]

  • 10. Metabolic profiles in patients with insulinoma.
    Hale PJ, Nattrass M.
    Clin Endocrinol (Oxf); 1989 Jan; 30(1):29-38. PubMed ID: 2550166
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The metabolic response to the euglycemic insulin clamp in type I diabetes and normal humans.
    Zuniga-Guajardo S, Zinman B.
    Metabolism; 1985 Oct; 34(10):926-30. PubMed ID: 3900631
    [Abstract] [Full Text] [Related]

  • 15. Hyperproinsulinaemia in patients with myotonic dystrophy.
    Krentz AJ, Clark PM, Cox L, Williams AC, Nattrass M.
    Diabetologia; 1992 Dec; 35(12):1170-2. PubMed ID: 1478370
    [Abstract] [Full Text] [Related]

  • 16. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy.
    Moxley RT, Griggs RC, Goldblatt D, VanGelder V, Herr BE, Thiel R.
    J Clin Invest; 1978 Oct; 62(4):857-67. PubMed ID: 701484
    [Abstract] [Full Text] [Related]

  • 17. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients.
    Krentz AJ, Dousset B, Mayer D, McMaster P, Buckels J, Cramb R, Smith JM, Nattrass M.
    Diabetes; 1993 Dec; 42(12):1753-9. PubMed ID: 7694879
    [Abstract] [Full Text] [Related]

  • 18. The relationship of plasma acetate with glucose and other blood intermediary metabolites in non-diabetic and diabetic subjects.
    Akanji AO, Humphreys S, Thursfield V, Hockaday TD.
    Clin Chim Acta; 1989 Oct 31; 185(1):25-34. PubMed ID: 2620451
    [Abstract] [Full Text] [Related]

  • 19. Insulin resistance in type 1 (insulin-dependent) diabetes: dissimilarities for glucose and intermediary metabolites.
    Nijs HG, Radder JK, Poorthuis BJ, Krans HM.
    Diabetes Res; 1990 Sep 31; 15(1):15-9. PubMed ID: 2132195
    [Abstract] [Full Text] [Related]

  • 20. Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.
    Beylot M, Khalfallah Y, Riou JP, Cohen R, Normand S, Mornex R.
    J Clin Endocrinol Metab; 1986 Jul 31; 63(1):9-15. PubMed ID: 3519651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.